Therapeutic Asset Ratings
6,308 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Panax Ginseng
Cancer
M.D. Anderson Cancer Center
P1/2
CCC
(48)
Panitumumab
Digestive System Cancer
Anup Kasi
P1/2
CCC
(48)
Panitumumab
Histiocytic And Dendritic Cell Neoplasm
Institut de Recherches Internationales Servier
P1/2
CCC
(48)
Panitumumab
Histiocytosis
Institut de Recherches Internationales Servier
P1/2
CCC
(48)
Panitumumab
Thyroid Gland Carcinoma
Institut de Recherches Internationales Servier
P1/2
CCC
(48)
Parsaclisib
Cognitive Impairment - Coarse Facies - Heart Defects - Obesity - Pulmonary Involvement - Short Stature - Skeletal Dysplasia Syndrome
Fudan University
P1/2
CCC
(48)
Pasifolate Exatecan
Endometrium Adenocarcinoma
Elucida Oncology
P1/2
CCC
(48)
Pasifolate Exatecan
Uterine Carcinosarcoma
Elucida Oncology
P1/2
CCC
(48)
Pasifolate Exatecan
Endometrial Clear Cell Adenocarcinoma
Elucida Oncology
P1/2
CCC
(48)
Pasifolate Exatecan
Endometrial Disorder
Elucida Oncology
P1/2
CCC
(48)
Pasifolate Exatecan
Endometrioid Adenocarcinoma
Elucida Oncology
P1/2
CCC
(48)
Pasifolate Exatecan
Endometrioid Tumor
Elucida Oncology
P1/2
CCC
(48)
Pasifolate Exatecan
Ovarian Adenocarcinoma
Elucida Oncology
P1/2
CCC
(48)
Pasifolate Exatecan
Ovarian Disorder
Elucida Oncology
P1/2
CCC
(48)
Patient Derived Cd19 Specific Car T Cells Also Expressing An Egfrt
Acute Leukemia
Seattle Children's Hospital
P1/2
CCC
(48)
Patritumab Deruxtecan
Breast Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris
P1/2
CCC
(48)
Patritumab Deruxtecan
HER2 Positive Breast Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris
P1/2
CCC
(48)
Patritumab Deruxtecan
Lung Cancer
Merck Sharp & Dohme LLC
P1/2
CCC
(48)
Paxalisib
Childhood Malignant Neoplasm
Australian & New Zealand Children's Haematology/Oncology Group
P1/2
CCC
(48)
Paxalisib
Cancer
Australian & New Zealand Children's Haematology/Oncology Group
P1/2
CCC
(48)
Pbgene-Dmd
Duchenne Muscular Dystrophy
Precision BioSciences, Inc.
P1/2
CCC
(48)
Pbgm01
GM1 Gangliosidosis
Gemma Biotherapeutics
P1/2
CCC
(48)
Pbkr03
Krabbe Disease
Gemma Biotherapeutics
P1/2
CCC
(48)
PCV 13
Hepatocellular Carcinoma
Mayo Clinic
P1/2
CCC
(48)
PCV 13
Intrahepatic Cholangiocarcinoma
Mayo Clinic
P1/2
CCC
(48)
Showing 1601 to 1625 of 6,308 assets
Previous
Page 65 of 253
Next